Valeant wins preliminary ruling in $150mn D&O coverage battle
  • X
  • LinkedIn
  • Show more sharing options
  • Print
  • X
  • LinkedIn
  • Free Trial
  • Log in

Valeant wins preliminary ruling in $150mn D&O coverage battle

John Hewitt Jones
May 28, 2019
  • X
  • LinkedIn
  • Show more sharing options
  • Print
  • X
  • LinkedIn

Drugs company Valeant scored a preliminary victory in a lawsuit over whether it is owed $150mn in coverage from directors’ and officers’ (D&O) insurers for a claim involving a failed acquisition of Botox manufacturer Allergan.

Request a free trial:

Fuel a smarter strategy with our actionable market intelligence

    • Gain a competitive edge and accelerate decision-making
    • Be empowered by insights that transform confusion to clarity
    • Uncover growth opportunities and prepare for potential threats
Request a free trial Already a subscriber? Log in now

Topics

NewsAIGLegalCasualty/GL
JJ
John Hewitt Jones
Gift this article